These results indicate that co-encapsulation of chemotherapeutic and anti-CSC agents in LNCs presents a potent strategy to tackle tumor heterogeneity, reduce recurrence, and enhance overall breast cancer therapy.83 Ashour et al investigated lactoferrin-coated flaxosules for efficient piperine and flaxseed oil co-delivery in breast cancer treatment. The gene discussed is LTF; the disease is breast carcinoma.